Literature DB >> 25491671

Peptide-mediated delivery: an overview of pathways for efficient internalization.

Janely Pae1, Margus Pooga.   

Abstract

Poor cellular delivery and low bioavailability of novel potent therapeutic molecules continue to remain the bottleneck of modern cancer and gene therapy. Cell-penetrating peptides have provided immense opportunities for the intracellular delivery of bioactive cargos and have led to the first exciting successes in experimental therapy of muscular dystrophies. This review focuses on the mechanisms by which cell-penetrating peptides gain access to the cell interior and deliver cargos. Recent advances in augmenting delivery efficacy and facilitation of endosomal escape of cargo are presented, and the cell-penetrating peptide-mediated delivery of two of the most popular classes of cargo molecules, oligonucleotides and proteins, is analyzed. The arsenal of tools for oligonucleotide delivery has dramatically expanded in the last decade enabling harnessing of cell-surface receptors for targeted delivery.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25491671     DOI: 10.4155/tde.14.72

Source DB:  PubMed          Journal:  Ther Deliv        ISSN: 2041-5990


  6 in total

1.  Efficient therapeutic delivery by a novel cell-permeant peptide derived from KDM4A protein for antitumor and antifibrosis.

Authors:  Hu Wang; Jie-Lan Ma; Ying-Gui Yang; Yang Song; Jiao Wu; Yan-Yan Qin; Xue-Li Zhao; Jun Wang; Li-Li Zou; Jiang-Feng Wu; Jun-Ming Li; Chang-Bai Liu
Journal:  Oncotarget       Date:  2016-08-02

2.  Innovative developments and emerging technologies in RNA therapeutics.

Authors:  François Halloy; Annabelle Biscans; Katherine E Bujold; Alexandre Debacker; Alyssa C Hill; Aurélie Lacroix; Olivia Luige; Roger Strömberg; Linda Sundstrom; Jörg Vogel; Alice Ghidini
Journal:  RNA Biol       Date:  2021-12-31       Impact factor: 4.652

3.  Ultrasound-Mediated Microbubble Destruction (UMMD) Facilitates the Delivery of CA19-9 Targeted and Paclitaxel Loaded mPEG-PLGA-PLL Nanoparticles in Pancreatic Cancer.

Authors:  Lingxi Xing; Qiusheng Shi; Kailiang Zheng; Ming Shen; Jing Ma; Fan Li; Yang Liu; Lizhou Lin; Wenzhi Tu; Yourong Duan; Lianfang Du
Journal:  Theranostics       Date:  2016-06-18       Impact factor: 11.556

4.  Liposome-encapsulated plasmid DNA of telomerase-specific oncolytic adenovirus with stealth effect on the immune system.

Authors:  Katsuyuki Aoyama; Shinji Kuroda; Toshiaki Morihiro; Nobuhiko Kanaya; Tetsushi Kubota; Yoshihiko Kakiuchi; Satoru Kikuchi; Masahiko Nishizaki; Shunsuke Kagawa; Hiroshi Tazawa; Toshiyoshi Fujiwara
Journal:  Sci Rep       Date:  2017-10-26       Impact factor: 4.379

5.  Development of Novel 111-In-Labelled DOTA Urotensin II Analogues for Targeting the UT Receptor Overexpressed in Solid Tumours.

Authors:  Benjamin Poret; Laurence Desrues; Marc-André Bonin; Martin Pédard; Martine Dubois; Richard Leduc; Romain Modzelewski; Pierre Decazes; Fabrice Morin; Pierre Vera; Hélène Castel; Pierre Bohn; Pierrick Gandolfo
Journal:  Biomolecules       Date:  2020-03-19

Review 6.  Cell-Penetrating Peptides and Transportan.

Authors:  Ülo Langel
Journal:  Pharmaceutics       Date:  2021-06-29       Impact factor: 6.321

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.